Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear

The proposed payment includes NANO stock, giving Radnostix an equity interest in the buyer upon closing.

Rhea-AI Summary

Radnostix (INIS) signed a definitive agreement to sell its nuclear fuel processing assets to NANO Nuclear Energy (NNE) and its subsidiary.

Consideration payable at closing consists of $9.5 million in cash and $4.0 million in NANO common stock. The assets include a Nuclear Regulatory Commission (NRC) license, patented technology and technical materials for depleted uranium hexafluoride processing and fluorine extraction. The licensed facility contemplated in Lea County, New Mexico, was not previously constructed.

The parties expect closing in approximately 90 to 120 days, subject to NRC consent to the license transfer, other required approvals including those from New Mexico officials, and satisfactory site arrangements. Radnostix intends to use net proceeds after closing to accelerate its four radioisotope technology product segments through research and development and organic and acquisition-led growth.

3 points · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate point. Forward-looking: it has not happened yet and may not happen.Asset sale would deliver $9.5 million in cash to Radnostix at closing. 1.1% of market cap
• Moderate point. Forward-looking: it has not happened yet and may not happen.Stock consideration would give Radnostix $4.0 million in NANO common stock at closing.
• Minor point. Forward-looking: it has not happened yet and may not happen.Radnostix plans to accelerate four radioisotope technology product segments using net proceeds after closing.

Negative

• Minor pointClosing requires NRC license-transfer consent, other approvals including New Mexico officials' consent, and satisfactory site arrangements.

Key Figures

Cash consideration: $9.5 million Stock consideration: $4.0 million Expected closing window: Approximately 90 to 120 days

Cash consideration

$9.5 million

Payable at closing under the asset purchase agreement

Stock consideration

$4.0 million

NANO common stock issuable at closing under the agreement

Expected closing window

Approximately 90 to 120 days

Parties' current expectation; timing depends on approvals and closing conditions

Key Terms

asset purchase agreement, nrc, 10 cfr part 40, duf6

4 terms

asset purchase agreement financial

"entered into a definitive asset purchase agreement with NANO Nuclear Energy Inc."

An asset purchase agreement is a legal contract in which a buyer agrees to buy specific assets and contracts of a business rather than buying the company’s stock or ownership. It matters to investors because it determines exactly what is being bought and what liabilities stay behind — like buying the furniture and equipment from a store but not the building or past debts — which affects the deal’s value, taxes and future risk exposure.

nrc regulatory

"including a U.S. Nuclear Regulatory Commission ("NRC") license"

The NRC is the government agency that oversees the safety, licensing, and regulation of nuclear power plants and other civilian uses of radioactive materials. Think of it as a specialized building inspector and permit office for anything involving nuclear materials: its reviews, approvals, inspections, or enforcement actions can change a facility’s operating status, timeline and costs, so investors watch the NRC for developments that could affect project delays, regulatory risks, liabilities and long‑term revenue.

10 cfr part 40 regulatory

"existing NRC 10 CFR Part 40 licensed fuel cycle assets"

A section of U.S. federal regulations that sets the safety, licensing and reporting rules for possessing and using certain nuclear source materials, such as uranium. Investors should care because companies working with these materials must obtain permits, meet ongoing safety requirements, and pass inspections; like needing a driver's license and vehicle inspections to operate, these rules can affect a firm's ability to operate, cost structure, project timelines and legal risk.

duf6 technical

"depleted uranium hexafluoride ("DUF6") deconversion"

DUF6 (depleted uranium hexafluoride) is the chemical compound produced as a byproduct of uranium enrichment that contains less of the fissile isotope U‑235 than natural uranium. It is handled and stored as a dense, corrosive material in cylinders; it reacts with moisture to form toxic and radioactive byproducts, so regulators treat it as a hazardous nuclear material that is typically kept under controlled conditions or converted to more stable forms for long‑term disposition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOISE, Idaho, Oct. 1, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ( "Radnostix" or the "Company") today announced that Radnostix and its wholly-owned subsidiary, International Isotopes Fluorine Products, Inc, have entered into a definitive asset purchase agreement with NANO Nuclear Energy Inc. (NASDAQ: NNE) and its wholly-owned subsidiary, HALEU Energy Fuel Inc., (collectively "NANO"), to divest its U.S. nuclear fuel processing assets, including a U.S. Nuclear Regulatory Commission ("NRC") license and related intellectual property and technical materials associated with depleted uranium hexafluoride ("DUF6") deconversion and fluorine extraction capabilities at a facility anticipated to be located in Lea County, New Mexico.

Transaction Terms and Next Steps

The proposed acquisition would provide NANO Nuclear with existing NRC 10 CFR Part 40 licensed fuel cycle assets and a substantial body of associated licensing and technical work. The NRC license was originally issued in connection with a proposed facility in Lea County, New Mexico designed to support DUF6 deconversion and fluorine extraction activities. The proposed acquisition also includes related patented technology, engineering and safety analyses, regulatory and permitting materials, equipment and historical project development records. The facility contemplated under the existing license was not previously constructed.

Under the asset purchase agreement, the consideration being paid for the assets at closing is $9.5 million in cash and $4.0 million in NANO common stock, payable and issuable at closing in accordance with the agreement.  Closing remains subject to NRC consent to the license transfer, other required approvals and consents (including from New Mexico officials), satisfactory site arrangements and other closing conditions. The parties currently expect closing in approximately 90 to 120 days, although the timing will depend on those approvals and conditions.

Radnostix Focus on Radioisotope Technologies

This transaction represents a major centering event for Radnostix, allowing the Company to focus on its core radioisotope technology segments while significantly strengthening its balance sheet for the next chapter of the business. Following closing, Radnostix intends to utilize the net proceeds to accelerate the growth of its four radioisotope technology product segments through a combination of enhanced research and development and continued organic and inorganic growth initiatives.

"We have complete confidence in NANO to take these DUF6 deconversion and fluorine extraction assets across the finish line and fill a material need for the U.S. Nuclear Fuel Cycle industry," said Shahe Bagerdjian, Chief Executive Officer of Radnostix. "The site, license, and technology sit squarely inside NANO's strategy to become a vertically integrated nuclear energy company, and we are excited to become NANO shareholders." Mr. Bagerdjian added, "For Radnostix, this transaction gives us the best of both worlds, allowing us to retain some upside via NNE stock while we can fully focus on our radioisotope technologies in medical and industrial applications.  We have a number of initiatives in our R&D & growth pipeline that upon closing Radnostix will be able to accelerate the development of.  While we have completed a few modest acquisitions over the past couple of years, the proceeds from the transaction will allow us to broaden our horizons, and fuel our growth rate."

About Radnostix (formerly International Isotopes Inc.): Radnostix, Inc. (formerly International Isotopes Inc.) (INIS), established in 1995, with its headquarters in Idaho Falls, ID, USA, manufactures a wide range of radioisotope technology products. Radnostix manufactures and supplies generic sodium iodide I-131 radio-pharmaceutical drug product for hyperthyroidism and thyroid cancer, the contract manufacturing of various drug products as well as radioisotope API supply for 3rd party theranostics clients. Radnostix also manufactures and distributes a complete line of calibration and reference standards for nuclear pharmacies and SPECT/PET imaging systems as well as industrial calibration standards under its RadQual brand. For more information, visit www.radnostix.com.

Radnostix, Inc. (formerly International Isotopes Inc.) Safe Harbor Statement:
Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including but not limited to, statements regarding the Company's current expected financial impact from the  Asset Purchase Agreement described herein, the estimated value of the DUF6 Plant and related assets, statements with respect to the Company's future growth expectations. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance, or achievements of Radnostix, Inc. to be materially different from any future results, performance or achievements of the Company expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in the Company's filings with the Securities and Exchange Commission at www.sec.gov, including its Annual Report on Form 10-K for the year ended December 31, 2025. Investors, potential investors, and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and Radnostix, Inc. and the Company undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Radnostix Contact: 
ir@intisoid.com
radnostix.com

 

View original content:https://www.prnewswire.com/news-releases/radnostix-signs-definitive-agreement-to-divest-duf6-and-fluorine-assets-to-nano-nuclear-302895541.html

SOURCE International Isotopes Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What will Radnostix receive for selling its nuclear fuel processing assets to NANO Nuclear?

Radnostix will receive $9.5 million in cash and $4.0 million in NANO common stock at closing under the definitive asset purchase agreement. Payment and share issuance remain dependent on the transaction closing.

When is the Radnostix asset sale to NANO Nuclear expected to close?

The parties expect closing in approximately 90 to 120 days. Timing depends on NRC consent to the license transfer, other required approvals and consents including those from New Mexico officials, satisfactory site arrangements and other closing conditions.